Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer

Conditions:   Oligometastatic Prostate Carcinoma;   Prostate Adenocarcinoma;   Stage IVB Prostate Cancer AJCC v8 Interventions:   Drug: Placebo Administration;   Other: Quality-of-Life Assessment;   Drug: Relugolix;   Radiation: Stereotactic Body Radiation Therapy Sponsors:   NRG Oncology;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials